Larson Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Larson Financial Group's XERS Position: Q3 2026 in Review
Larson Financial Group held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 955 shares worth $9.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2562.
Larson Financial Group first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Larson Financial Group held 955 shares of Xeris Biopharma Holdings worth $9.13K as of Q3 2026.
- Larson Financial Group left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2562 holding.
- Larson Financial Group first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
- 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.